113
Participants
Start Date
July 13, 2022
Primary Completion Date
December 2, 2024
Study Completion Date
December 2, 2024
Linaprazan glurate
"Linaprazan glurate base formulation, 25 mg oral tablets (300 mg and 600 mg doses).~Linaprazan glurate hydrochloride (HCl), 25 mg and 100 mg (as base) oral tablets (200 mg and final dose level of maximum 400 mg)."
Placebo
Single dose, oral tablets
RECRUITING
CTC Clinical Trial Consultants AB, Uppsala
Lead Sponsor
Cinclus Pharma AG
INDUSTRY